Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic

Published:2017-01-10 Issue:2 Volume:317 Page:139
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Middleton John P.¹,Wolf Myles¹

Affiliation:

1. Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore;Cureus;2023-11-02

2. Calcimimetika – Update 2022;Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen;2022-04-29

3. Regulation and Effects of FGF23 in Chronic Kidney Disease;Annual Review of Physiology;2020-02-10

4. New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology;Journal of Nephrology;2019-12-18

5. Discovery of Etelcalcetide for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease;Successful Drug Discovery;2019-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP